Clinical Trial Update: Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for 611 in Chinese adults with moderate to severe atopic dermatitis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• 611

Snippet

Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | Conditions: Dermatitis, Atopic | Phase 2 | Status: COMPLETED